Andrea Natale MD, FACC
Executive Medical Director
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Dr. Natale is the Executive Medical Director of the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas, and the National Medical Director of Cardiac Electrophysiology for HCA Healthcare.
Dr. Natale is board certified in Cardiology and Clinical Cardiac Electrophysiology.
He is a dedicated researcher who has pioneered several innovative advances in the treatment of atrial fibrillation (Afib), including some of the current catheter-based cures for atrial fibrillation, a new circumferential ultrasound vein-ablation system to correct atrial fibrillation and was the nation’s first electrophysiologist to perform percutaneous epicardial radiofrequency ablation. Dr. Natale has held faculty positions at Duke University, Case Western Reserve University, Stanford University and the Dell Medical School at the University of Texas at Austin.
Sanghamitra Mohanty. MD, MS, FHRS
Director of Research
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Dr. Mohanty serves as the Director of Research at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center. Currently, Dr. Mohanty is involved in leading several major research projects and clinical trials in patients with atrial fibrillation (Afib).
Dr. Mohanty performed post-graduate studies at the University of North Texas Health Science Center in Fort Worth, Texas and worked as a researcher and faculty at The University of Texas at Austin. At UT, she was directly involved in the development of novel tests to detect cardiac biomarkers for the diagnosis and monitoring of treatment in heart disease. Dr. Mohanty is an affiliate faculty member at Dell Medical School, Austin, TX.
Luis Gandia, PHD, MD
Full Professor of Pharmacology and
Chairman of the Department of Pharmacology and Therapeutics
Luis Gandia is currently Full Professor of Pharmacology and Chairman of the Department of Pharmacology and Therapeutics at Autonomous University of Madrid.
He obtained his PhD in Neuroscience from the University of Alicante in 1990.
He dedicated his postdoctoral work at the University of Pennsylvania in specializing in electrophysiological and microscopy techniques. During his career, Luis has a wide-ranging experience in all phases of pharmacological development, with a particular emphasis on the preclinical development of new drugs.
FRED STEVENS, MSC, PharmD, PHD
Principal Investigator, Linus Pauling Institute.
Associate Dean for Research and Professor of Pharmaceutical Sciences, Department of Pharmaceutical Sciences, College of Pharmacy.
Dr. Jan Frederik (‘Fred’) Stevens is a Principal Investigator and is Professor of Pharmaceutical Sciences in the College of Pharmacy and Associate Director for Research in the Linus Pauling Institute at Oregon State University in Corvallis.
Dr. Stevens has authored more than 135 research articles in peer-review journals, 39 of which report on the chemistry and pharmacology of xanthohumol. He received five awards for excellence in teaching at the OSU College of Pharmacy. He holds a guest professorship at the University of Antwerp, Belgium.
His research covers the role and function of dietary phytochemicals in human health and disease. Mass spectrometry-based metabolomics is a major research tool in his laboratory for the discovery of biological effects of vitamins and phytochemicals in cultured cells, animal models of disease, and in humans. He is the world´s leading expert in xanthohumol and its applications in human health.